argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. ACN
9. AZN
10. SPCX

Go back to argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline
(NASDAQ: FBRX) Delayed: 76.99 --0 (-0%)
Previous Close $76.99    52 Week High $ 
Open $76.99    52 Week Low $ 
Day High $76.99    P/E N/A 
Day Low $76.99    EPS $ 
Volume 7,104,686